Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 163, Issue 1, Pages 141-172Publisher
WILEY
DOI: 10.1111/j.1476-5381.2011.01247.x
Keywords
pulmonary fibrosis; fibrosis therapy; drug targets; myofibroblast
Categories
Funding
- Wellcome Trust [084382/Z/07/Z]
- MRC [G0800340, 2009-12]
- European Commission [HEALTH-F2-2007-2224]
- BBSRC [BB/I532702/1]
- GlaxoSmithKline
- Novartis
- BBSRC [BB/I532702/1] Funding Source: UKRI
- MRC [G0800340] Funding Source: UKRI
- Wellcome Trust [084382/Z/07/Z] Funding Source: Wellcome Trust
- Medical Research Council [G0800340] Funding Source: researchfish
Ask authors/readers for more resources
LINKED ARTICLES This article is part of a themed issue on Respiratory Pharmacology. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.163.issue-1.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
